Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
S Redenšek, D Flisar, M Kojović… - Frontiers in …, 2019 - frontiersin.org
Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's
disease. Several studies reported associations of dopaminergic genes with the occurrence …
disease. Several studies reported associations of dopaminergic genes with the occurrence …
[HTML][HTML] Pharmacogenetic markers of adverse events of dopaminergic treatment in Parkinson's disease
S Redenšek - 2019 - repozitorij.uni-lj.si
Parkinson's disease (PD) is a complex neurological disease that affects 1 to 1.5% of people
older than 65 years. At its core, PD is a neurodegenerative disease affecting particular basal …
older than 65 years. At its core, PD is a neurodegenerative disease affecting particular basal …